Sascha Auerbach

Safety and tolerability of the β₃‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial

Christopher R. Chapple, C. Walters, Mary Beth Blauwet et al. · International Journal of Clinical Practice · 2014 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Reminiscence Interviews as Stress Management Interventions for Older Patients Undergoing Surgery

Bruce Rybarczyk, Sascha Auerbach · The Gerontologist · 1990 · 56 citations

Medicine, Geriatric Medicine, Surgery +15

885 THE EFFICACY AND SAFETY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME – RESULTS FROM A NORTH-AMERICAN PHASE III TRIAL

Sender Herschorn, Sascha Auerbach, Mark Ayers et al. · European Urology Supplements · 2011 · 46 citations

Medicine, Pharmacotherapy, Urology +6

Long-term safety and efficacy of oral phentolamine mesylate (Vasomax®) in men with mild to moderate erectile dysfunction

Harin Padma-Nathan, Irwin Goldstein, Ira Klimberg et al. · International Journal of Impotence Research · 2002 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +9

First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I

Luc Valiquette, Francesco Montorsi, Sascha Auerbach · International Journal of Clinical Practice · 2006 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10